Siblings

兄弟姐妹
  • 文章类型: Journal Article
    背景:虽然文献强调了照顾家庭成员的巨大挑战,目前尚不清楚智力残疾和具有挑战性行为的家庭照顾者的需求是什么,以及对他们有什么好处。这项研究旨在研究60名父母和兄弟姐妹在管理成年家庭成员在家中生活时具有智力障碍的挑战性行为方面的经验。
    方法:将采用半结构化访谈的定性扎根理论方法。目的抽样将用于招募与智障成年人生活在一起并在香港使用一项社区服务的家庭照顾者。将接触来自中国北方的三所智力残疾人特殊学校。
    结果:本研究旨在深入了解家庭照顾者的经历,并比较他们在家庭中处理智障成年亲属的挑战性行为时所面临的不同情况。
    结论:尽管这项研究针对的是有智力障碍的成年人,研究结果将为表现出苛刻和挑战行为并与家人生活在一起的青少年和年轻人提供参考。建议可以指导制定适当的战略,以加强对家庭照顾者的服务。
    BACKGROUND: While the literature has highlighted the immense challenges in caring for family members, it is still unclear what the needs of family carers of persons with intellectual disability and challenging behaviours are and what has worked for them. This study aims to examine 60 parents\' and siblings\' experiences in managing the challenging behaviours of their adult family member with intellectual disability whilst living at home.
    METHODS: A qualitative grounded theory approach using semi-structured interviews will be adopted. Purposive sampling will be used to recruit family carers who live with adult persons with intellectual disability and use one community service in Hong Kong. Three special schools for persons with intellectual disability from northern China will be approached.
    RESULTS: This study will aim to provide an in-depth understanding of the experiences of family carers and compare the different circumstances they face when managing the challenging behaviours of their adult relatives with intellectual disability in their family home.
    CONCLUSIONS: Although this study targets adults with intellectual disability, the findings will provide a point of reference for adolescents and younger persons who exhibit demanding and challenging behaviours and live with their families. Recommendations can guide the development of appropriate strategies to strengthen services for family carers.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Letter
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    巴利昔单抗是类固醇难治性急性移植物抗宿主病(SR-aGVHD)的重要治疗方法。我们进行了这项回顾性研究,以评估匹配同胞供者造血干细胞移植(MSD-HSCT)后SR-aGVHD患者中巴利昔单抗治疗的疗效和安全性(n=63)。在巴利昔单抗治疗后的任何时间和第28天,总缓解率(ORR)分别为63.5%和54%。巴利昔单抗治疗前III-IV级aGVHD预测巴利昔单抗治疗后ORR较差。病毒的比率,细菌,真菌感染占54%,23.8%,和3.1%,分别。中位随访时间为730(范围,67-3,042)天,巴利昔单抗治疗后1年总生存率和无病生存率分别为58.6%(95%置信区间[CI]=47.6%-72.2%)和55.4%(95%CI=44.3%-69.2%),分别。巴利昔单抗治疗后3年累积复发和非复发死亡率分别为18.9%(95%CI=8.3%-29.5%)和33.8%(95%CI=21.8%-45.7%),分别。allo-HSCT之前的合并症负担,巴利昔单抗治疗前aGVHD和肝脏aGVHD的严重程度对生存率有负面影响.因此,巴利昔单抗是MSD-HSCT后SR-aGVHD安全有效的治疗方法。
    Basiliximab is an important treatment for steroid-refractory acute graft-versus-host disease (SR-aGVHD). We performed this retrospective study to evaluate the efficacy and safety of basiliximab treatment in SR-aGVHD patients following matched sibling donor hematopoietic stem cell transplantation (MSD-HSCT) (n = 63). Overall response rate (ORR) was 63.5% and 54% at any time and at day 28 after basiliximab treatment. Grade III-IV aGVHD before basiliximab treatment predicted a poor ORR after basiliximab treatment. The rates of virus, bacteria, and fungi infections were 54%, 23.8%, and 3.1%, respectively. With a median follow-up of 730 (range, 67-3,042) days, the 1-year probability of overall survival and disease-free survival after basiliximab treatment were 58.6% (95% confidence interval [CI] = 47.6%-72.2%) and 55.4% (95% CI = 44.3%-69.2%), respectively. The 3-year cumulative incidence of relapse and non-relapse mortality after basiliximab treatment were 18.9% (95% CI = 8.3%-29.5%) and 33.8% (95% CI = 21.8%-45.7%), respectively. Comorbidities burden before allo-HSCT, severity of aGVHD and liver aGVHD before basiliximab treatment showed negative influences on survival. Thus, basiliximab was safe and effective treatment for SR-aGVHD following MSD-HSCT.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在典型的时代,青少年与家庭成员的关系会影响认知的变化,社会,和身体方面的发展。COVID-19大流行,然而,以前所未有的方式影响了整个家庭系统。全世界的青少年学者被驱使去了解青少年与家庭成员的关系是如何由于这些戏剧性的社会变化而改变的,以及这些关系对青少年福祉的影响。这项系统评价研究了2020-2022年间发表的189篇文章的两个研究问题:(1)COVID-19大流行如何影响有青少年的家庭,包括更广泛的家庭功能,家庭关系品质,和育儿?(2)大流行或与大流行相关的压力源如何与家庭功能相互作用,家庭关系,和为青少年父母影响青少年的福祉和适应?此外,对相关研究的检查分为大流行影响的子主题:(a)家庭环境和常规,(b)家庭困难,(c)育儿和父母与青少年的关系,(d)兄弟关系。
    In typical times, adolescents\' relationships with family members influence changing cognitive, social, and physical aspects of their development. The COVID-19 pandemic, however, impacted the full family system in ways that were unprecedented. Scholars of adolescence worldwide were driven to understand how adolescents\' relationships with family members changed due to these dramatic societal shifts and the influence these relationships had on adolescents\' well-being. This systematic review examined two research questions with 189 articles published from 2020-2022: (1) How has the COVID-19 pandemic impacted families with adolescents, including broader family functioning, family relationship qualities, and parenting? and (2) How has the pandemic or pandemic-related stressors interacted with family functioning, family relationships, and parenting of adolescents to impact adolescent well-being and adjustment? Additionally, examination of the relevant studies were divided into sub-themes of pandemic influence: (a) family environment and routines, (b) family difficulties, (c) parenting and parent-adolescent relationships, and (d) sibling relationships.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    对于核心结合因子突变(CBF)的AML患者,建议进行异基因造血细胞移植(allo-HCT),以实现第二次完全缓解(CR2)。然而,约20%的患者可能在移植后复发,供者偏好仍不清楚.我们在这个EBMT全球多中心注册分析中比较了使用单倍体(Haplo)的allo-HCT结果,配对的兄弟姐妹捐赠者(MSD),或10/10匹配的无关供体(MUD)。分析了2010年至2022年在227个EBMT中心接受allo-HCT的CR2中865名成人CBFAML患者的数据,其中329MSD,374MUD,纳入162例Haplo-HCTs。对于整个队列,503例(58%)患者为inv(16)/CBFB-MYH11,362例(42%)为t(8;21)/RUNX1-RUNX1T1AML。在多变量分析中,与MSD(风险比[HR]=0.56,95%CI0.32-0.97;p<0.05)或MUD(HR=0.57,95%CI:0.33-0.99,p<0.05)相比,Haplo-HCT与较低的复发发生率(RI)相关。在LFS上的3种类型的供体之间没有观察到显著差异,OS和GRFS。与具有inv(16)的CBF-AML相比,具有t(8;21)的CBF-AML与更高的RI(HR=1.79,95%CI1.3-2.47;p<0.01)和更高的NRM(HR=1.58,95%CI1.1-2.27;p<0.01)相关,这导致了更糟糕的LFS,OS和GRFS。最后,对于CR2的CBF-AML患者,与MSD和MUDallo-HCTs相比,Haplo-HCTs的RI较低.在LFS上没有区别,OS或GRFS。在CR2中进行allo-HCT后,inv(16)的CBFAML患者的孕激素优于t(8;21)。
    Allogeneic hematopoietic cell transplantation (allo-HCT) is recommended for core-binding factor mutated (CBF) AML patients achieving second complete remission (CR2). However, approximately 20% of patients may relapse after transplant and donor preference remains unclear. We compared in this EBMT global multicenter registry-based analysis the allo-HCT outcomes using either haploidentical (Haplo), matched siblings donors (MSD), or 10/10 matched unrelated donors (MUD). Data from 865 de novo adult CBF AML patients in CR2 receiving allo-HCT in 227 EBMT centers from 2010 to 2022 were analyzed, in which 329 MSD, 374 MUD, and 162 Haplo-HCTs were included. For the entire cohort, 503 (58%) patients were inv(16)/CBFB-MYH11 and 362 patients (42%) were t(8;21)/RUNX1-RUNX1T1 AML. On multivariate analysis, Haplo-HCT was associated with a lower Relapse Incidence (RI) compared to either MSD (hazard ratio [HR] = 0.56, 95% CI 0.32-0.97; p < .05) or MUD (HR = 0.57, 95% CI: 0.33-0.99, p < .05). No significant difference was observed among the 3 types of donors on LFS, OS and GRFS. CBF-AML with t(8;21) was associated with both higher RI (HR = 1.79, 95% CI 1.3-2.47; p < .01) and higher NRM (HR = 1.58, 95% CI 1.1-2.27; p < .01) than CBF-AML with inv(16), which led to worse LFS, OS and GRFS. To conclude, for CBF-AML patients in CR2, Haplo-HCTs were associated with a lower RI compared to MSD and MUD allo-HCTs. There was no difference on LFS, OS or GRFS. CBF AML patients with inv(16) had a better progonosis than those with t(8;21) after allo-HCT in CR2.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: English Abstract
    Objective: To evaluate the efficacy of allogeneic hematopoietic stem cell transplantation for the treatment of combined immunodeficiency (CID) and explore prognostic risk factors. Methods: In this retrospective cohort study, clinical characteristics, laboratory tests and prognosis of 73 CID children who underwent allogeneic hematopoietic stem cell transplantation from February 2014 to April 2022 in the Children\'s Hospital of Fudan University were analyzed. Based on the subtypes of diseases, all patients were divided into severe combined immunodeficiency disease (SCID) group and other CID group. Based on the types of donors, all patients were divided into matched sibling donor group, matched unrelated donor group, unrelated cord blood group, and haploidentical donor group. Kaplan-Meier method and Log-Rank test were used to analyze the survival data. Cox regression was used to analyze prognostic factors. Results: Among the 73 patients, there were 61 (84%) males and 12 (16%) females. Fifty-five (75%) patients were SCID, and 18 (25%) patients were other CID. Donor source included 2 (3%) matched sibling donors (MSD), 3 (4%) matched unrelated donors (MUD), 64 (88%) unrelated cord blood (UCB), and 4 (5%) haploidentical donors. The age at transplant was 10.7 (5.9, 27.5) months, and the follow-up time was 36.2 (2.5, 62.9) months. The 3-year overall survival rate of 73 patients with CID was (67±6) %. No significant difference was found in the 3-year overall survival rates between patients with SCID (55 cases) and other CID (18 cases) ((64±7) % vs. (78±10) %, χ2=1.31, P=0.252). And no significant difference was found in the 3-year overall survival rates among patients who received MSD or MUD (5 cases), UCB (64 cases), and haploidentical donor (4 cases) transplant (100% vs. (66±6)% vs. (50±25) %, χ2=2.30, P=0.317). Cox regression analysis showed that the medical history of sepsis (HR=2.55, 95%CI 1.05-6.20, P=0.039) and hypoalbuminemia at transplant (HR=2.96, 95%CI 1.14-7.68, P=0.026) were independent risk factors for the prognosis of allogeneic hematopoietic stem cell transplantation in pediatric patients with CID. Conclusions: Allogeneic hematopoietic stem cell transplantation is an effective treatment for CID. The medical history of sepsis and hypoalbuminemia at transplant were risk factors for prognosis. Enhancing infection prevention and nutritional intervention before transplant can improve patient prognosis.
    目的: 评价异基因造血干细胞移植治疗联合免疫缺陷病(CID)的效果并探讨预后相关因素。 方法: 回顾性队列研究。收集2014年2月至2022年4月复旦大学附属儿科医院行异基因造血干细胞移植治疗的73例CID患儿的临床特征、实验室检查及预后。根据疾病亚型分为重症联合免疫缺陷病(SCID)组和其他CID组,根据供者类型分为同胞相合供者组、非亲缘相合供者组、非亲缘脐带血组及单倍体供者组,采用Kaplan-Meier法对患儿进行生存分析并进行Log-Rank检验,Cox回归分析预后危险因素。 结果: 73例患儿中男61例(84%)、女12例(16%)。SCID 55例(75%),其他CID18例(25%)。同胞相合供者、非亲缘相合供者、非亲缘脐带血及单倍体供者分别为2例(3%)、3例(4%)、64例(88%)及4例(5%)。移植年龄10.7(5.9,27.5)月龄,随访时间36.2(2.5,62.9)个月。73例CID患儿的3年总生存率为(67±6)%。SCID组(55例)与其他CID组(18例)患儿3年总生存率差异无统计学意义[(64±7)%比(78±10)%,χ2=1.31,P=0.252]。同胞或非亲缘相合供者移植组(5例)、非亲缘脐带血移植组(64例)及单倍体供者移植组(4例)患儿3年总生存率分别为100%、(66±6)%、(50±25)%,组间比较差异无统计学意义(χ2=2.30,P=0.317)。Cox回归分析显示败血症病史(HR=2.55,95%CI 1.05~6.20,P=0.039)及移植前低白蛋白血症(HR=2.96,95%CI 1.14~7.68,P=0.026)是影响CID患儿移植预后的独立危险因素。 结论: 异基因造血干细胞移植治疗CID有效,移植前有败血症病史及低白蛋白血症是患儿预后危险因素,加强移植前感染预防及营养干预可改善患儿预后。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    本文确定了女孩由于有一个来自内源性兄弟姐妹性别组成的兄弟而遭受的健康惩罚。我们提出了一种女孩对女孩的比较策略,并排除了同胞大小的混淆效应,出生间隔,出生顺序采用工具变量方法和来自中国家庭面板研究的数据,我们发现有兄弟的女孩明显较矮,健康状况较差。这个“兄弟的惩罚”甚至在出生前就显现出来了。替代解释,如出生顺序的缺点,被仔细处理并排除在外。即使排除了不分性别的少数民族,结果仍然有效。这种观察到的惩罚可能归因于家庭内部资源分配不平等和潜在的父母忽视。这种惩罚在低收入和母亲教育程度较低的家庭中被放大,这意味着资源限制会导致性别歧视。我们的发现强调了解决家庭内性别偏见对确保平等机会和健康结果的重要性。临床试验注册:不适用。
    This paper identifies the health penalty experienced by girls due to having a brother from endogenous sibling gender composition. We propose a girls-to-girls comparison strategy and rule out the confounding effect from the sibship size, birth interval, and birth order. Employing an instrumental variable approach and data from the Chinese Family Panel Studies, we find that girls with a brother are demonstrably shorter and report poorer health. This \"brother\'s penalty\" manifests even prenatally. Alternative explanations, such as birth order disadvantages, are carefully addressed and ruled out. The results hold even after excluding gender-neutral ethnic minorities. This observed penalty is likely attributed to unequal resource allocation within families and potential parental neglect. This penalty is amplified in families with lower income and maternal education, implying resource constraints contribute to gender discrimination. Our findings highlight the importance of addressing intrafamily gender bias for ensuring equal opportunities and health outcomes. Clinical trial registration: Not applicable.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:在应对压力环境时,积极发展在青年中起着重要作用。根据资源稀释理论,有或没有兄弟姐妹的青少年可能会从父母那里获得不同程度的情感和物质资源。这项研究的目的是研究当今中国青少年的积极发展与他们的家庭特征之间的关系,例如兄弟姐妹的数量。
    方法:成都市2072名初中和高中学生(13至18岁),四川,中国,通过整群抽样进行了调查。使用中国积极青年发展量表(CPYDs)来衡量积极青年发展。广义线性模型用于探索兄弟姐妹数量之间的关系,亲子关系和积极的青年发展。
    结果:独生子女家庭的青少年在积极发展方面表现更好(H=21.87,P<0.001),与父母的关系更好(H=15.1,P<0.05)。男女青少年的积极发展在兄弟姐妹数量不同的家庭中没有显着差异。广义线性模型显示亲子关系与青少年正发育呈正相关(P<0.05)。
    结论:积极的青年发展不仅与兄弟姐妹的数量有关,还与其他可改变的家庭因素有关。父母与青少年之间的积极关系在日常生活中对促进青少年发展具有重要的实用价值,这可能是资源稀释理论的真正教训。
    BACKGROUND: Positive development plays an important role in youth when dealing with stressful circumstances. According to the resource dilution theory, adolescents with or without siblings may receive different levels of emotional and material resources from their parents. The purpose of this study is to examine the association between the positive development of adolescents in China today with their family characteristics such as the number of siblings.
    METHODS: A total of 2072 junior high and senior high school students (13 to 18 years old) in Chengdu, Sichuan, China, were investigated by cluster sampling. The Chinese Positive Youth Development scales (CPYDs) were used to measure positive youth development. The generalized linear model was used to explore the relationships among the number of siblings, parent-child relationships and positive youth development.
    RESULTS: Adolescents from only-child families had better performance on positive development (H = 21.87, P < 0.001) and better relationships with parents (H = 15.1, P < 0.05). The positive development of male and female adolescents does not significantly differ in families with different numbers of siblings. The generalized linear model showed that a positive parent-child relationship is positively correlated with adolescent positive development (P < 0.05).
    CONCLUSIONS: Positive youth development is not only associated with the number of siblings but also other modifiable familial factors. The positive relationship between parents and adolescents is of great practical value in daily life to improve youth development, and this might be the real lesson the resource dilution theory tells.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:以前,基于毛细管电泳平台构建了一个新的64个基因座的多重系统,包括59个常染色体插入/缺失(A-InDels),两个Y染色体InDels,两个迷你短串联重复(miniSTR),和Amelogenin基因.这项研究的目的是评估这种多重系统对个体识别的效率,中国贺州汉族(CHH)和湖北土家族(CTH)群体的亲子鉴定和生物地理血统推断,为法医人类学和人口遗传学研究提供有价值的见解。
    结果:59个A-InDels和两个miniSTR的辨别力(CDP)和排除概率(CPE)的累积值为0.999999999999999999999999999999754,0.9999999905;CTH和CHH组中的0.99999999999999999999998,0.999999999898,分别。当似然比阈值设置为1或10时,可以从无关的个体对中识别出超过95%的完整兄弟对。CTH组和CHH组假阳性率均低于1.2%。利用三种算法构建了基于35个种群的生物地理祖先推理模型:随机森林,自适应增强和极端梯度增强,然后应用10倍交叉验证分析来测试这三个模型,平均准确率为86.59%,84.22%和87.80%,分别。此外,我们还使用FST的群体统计方法调查了两个研究组与33个参考群体之间的遗传关系,DA,系统发育树,PCA,结构和TreeMix分析。目前的结果表明,与其他大陆人口相比,CTH和CHH组与东亚人群的遗传亲和力较高.
    结论:该新型多重系统在CTH和CHH组中具有较高的CDP和CPE,它可以用作个人识别和亲子鉴定的有力工具。根据各种遗传分析方法,CTH和CHH群体的遗传结构与参考东亚群体相对相似。
    BACKGROUND: Previously, a novel multiplex system of 64 loci was constructed based on capillary electrophoresis platform, including 59 autosomal insertion/deletions (A-InDels), two Y-chromosome InDels, two mini short tandem repeats (miniSTRs), and an Amelogenin gene. The aim of this study is to evaluate the efficiencies of this multiplex system for individual identification, paternity testing and biogeographic ancestry inference in Chinese Hezhou Han (CHH) and Hubei Tujia (CTH) groups, providing valuable insights for forensic anthropology and population genetics research.
    RESULTS: The cumulative values of power of discrimination (CDP) and probability of exclusion (CPE) for the 59 A-InDels and two miniSTRs were 0.99999999999999999999999999754, 0.99999905; and 0.99999999999999999999999999998, 0.99999898 in CTH and CHH groups, respectively. When the likelihood ratio thresholds were set to 1 or 10, more than 95% of the full sibling pairs could be identified from unrelated individual pairs, and the false positive rates were less than 1.2% in both CTH and CHH groups. Biogeographic ancestry inference models based on 35 populations were constructed with three algorithms: random forest, adaptive boosting and extreme gradient boosting, and then 10-fold cross-validation analyses were applied to test these three models with the average accuracies of 86.59%, 84.22% and 87.80%, respectively. In addition, we also investigated the genetic relationships between the two studied groups with 33 reference populations using population statistical methods of FST, DA, phylogenetic tree, PCA, STRUCTURE and TreeMix analyses. The present results showed that compared to other continental populations, the CTH and CHH groups had closer genetic affinities to East Asian populations.
    CONCLUSIONS: This novel multiplex system has high CDP and CPE in CTH and CHH groups, which can be used as a powerful tool for individual identification and paternity testing. According to various genetic analysis methods, the genetic structures of CTH and CHH groups are relatively similar to the reference East Asian populations.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    Angelman综合征(AS,MIM#105830)是一种神经发育障碍,其特征是严重的智力残疾,严重的发育迟缓,运动或平衡问题,过分开朗的性格,和癫痫发作。母本UBE3A基因表达不充分的AS结果(MIM#601623),它在泛素-蛋白酶体途径中编码E3连接酶。在这里,我们介绍了两个姐妹的情况,这些姐妹的特征与AS一致,他们的甲基化分析为阴性。自闭症/智力障碍扩展小组显示,两名患者的母系遗传新型UBE3A(NM_001354506.2)变异c.2443C>Tp。(Pro815Ser)最初被归类为不确定意义的变异。这些患者被纳入印第安纳大学的未诊断罕见病诊所(URDC),以进一步研究该变异。附加数据,包括深层表型,家庭隔离分析,在计算机研究中,表明该变异可能是致病的。基于现有晶体结构的3D建模研究表明,Pro815Ser变体可以为蛋白质引入更多的灵活性并改变其酶活性。最近的文献证实了该变体的致病性。对UBE3A变体的重新分析提高了对AS的现有知识,并为该家族的诊断冒险之旅提供了终结。
    Angelman syndrome (AS, MIM #105830) is a neurodevelopmental disorder characterized by severe intellectual disability, profound developmental delay, movement or balance problems, an excessively cheerful disposition, and seizures. AS results from inadequate expression of the maternal UBE3A gene (MIM #601623), which encodes an E3 ligase in the ubiquitin-proteasome pathway. Here we present the case of two sisters with features consistent with AS who had negative methylation analyses. An autism/intellectual disability expanded panel revealed a maternally inherited novel UBE3A (NM_001354506.2) variant c.2443C>T p.(Pro815Ser) in both patients that was initially classified as a variant of uncertain significance. The patients were enrolled in Indiana University\'s Undiagnosed Rare Disease Clinic (URDC) to further investigate the variant. Additional data, including deep phenotyping, familial segregation analysis, and in silico studies, suggest that the variant is likely pathogenic. 3D modeling studies based on the available crystal structure revealed that the Pro815Ser variant can introduce more flexibility into the protein and alter its enzymatic activity. Recent literature confirms the pathogenic nature of the variant. Reanalysis of the UBE3A variant has heightened existing knowledge of AS and has offered this family an end to their diagnostic odyssey.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号